TPD52 Antikörper (AA 141-190)
Kurzübersicht für TPD52 Antikörper (AA 141-190) (ABIN720745)
Target
Alle TPD52 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 141-190
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Cow,Sheep,Pig,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TPD52
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma." in: Oncotarget, Vol. 7, Issue 5, pp. 6323-34, (2017) (PubMed).
-
: "Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma." in: Oncotarget, Vol. 7, Issue 5, pp. 6323-34, (2017) (PubMed).
-
- TPD52 (Tumor Protein D52 (TPD52))
-
Andere Bezeichnung
- Prostate and colon associated protein
-
Hintergrund
-
Synonyms: D52, N8L, PC-1, PrLZ, hD52, Tumor protein D52, Protein N8, TPD52
Background: Isoform 2 is expressed in colon, breast, prostate, pancreas and kidney tumor cell lines. Isoform 2 is expressed at high levels in kidney, prostate, brain, small intestine and pancreas, at moderate levels in placenta and colon, at low levels in lung, liver and heart, and at very low levels in spleen, thymus, peripheral mononuclear blood cells, testis and ovary.
-
Gen-ID
- 7163
-
UniProt
- P55327
Target
-